BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33463100)

  • 1. Intravenous Immunoglobulin Therapy in Myocarditis.
    Mansourabadi AH; Gol Mohammad Pour Afrakoti L; Shahi A; Shabanian R; Amirzargar A
    Iran J Allergy Asthma Immunol; 2020 Aug; 19(4):323-336. PubMed ID: 33463100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins.
    Maisch B; Hufnagel G; Kölsch S; Funck R; Richter A; Rupp H; Herzum M; Pankuweit S
    Herz; 2004 Sep; 29(6):624-36. PubMed ID: 15912438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of viral myocarditis caused by coxsackievirus B.
    Brunetti L; DeSantis ER
    Am J Health Syst Pharm; 2008 Jan; 65(2):132-7. PubMed ID: 18192257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress.
    Kishimoto C; Shioji K; Kinoshita M; Iwase T; Tamaki S; Fujii M; Murashige A; Maruhashi H; Takeda S; Nonogi H; Hashimoto T
    Int J Cardiol; 2003 Oct; 91(2-3):173-8. PubMed ID: 14559127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin - indications and mechanisms in cardiovascular diseases.
    Nussinovitch U; Shoenfeld Y
    Autoimmun Rev; 2008 Jun; 7(6):445-52. PubMed ID: 18558360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin treatment for acute fulminant inflammatory cardiomyopathy: series of six patients and review of literature.
    Goland S; Czer LS; Siegel RJ; Tabak S; Jordan S; Luthringer D; Mirocha J; Coleman B; Kass RM; Trento A
    Can J Cardiol; 2008 Jul; 24(7):571-4. PubMed ID: 18612500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fulminant myocarditis successfully treated with high-dose immunoglobulin.
    Kim HS; Sohn S; Park JY; Seo JW
    Int J Cardiol; 2004 Sep; 96(3):485-6. PubMed ID: 15301907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lupus myocarditis: marked improvement in cardiac function after intravenous immunoglobulin therapy.
    Suri V; Varma S; Joshi K; Malhotra P; Kumari S; Jain S
    Rheumatol Int; 2010 Sep; 30(11):1503-5. PubMed ID: 19697032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-hospital and post-discharge outcomes of pediatric acute myocarditis underwent after high-dose steroid or intravenous immunoglobulin therapy.
    Lin MS; Tseng YH; Chen MY; Chung CM; Tsai MH; Wang PC; Chang JJ; Chen TH; Lin YS
    BMC Cardiovasc Disord; 2019 Jan; 19(1):10. PubMed ID: 30626332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic effect of intravenous immunoglobulins and vitamin C on the progression of experimental autoimmune myocarditis in the mouse.
    Gong F; Hu Y; Chen L; Gu W
    Med Sci Monit; 2007 Nov; 13(11):BR240-246. PubMed ID: 17968290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus acute cardiomyopathy is highly responsive to intravenous immunoglobulin treatment: Case series and literature review.
    Meridor K; Shoenfeld Y; Tayer-Shifman O; Levy Y
    Medicine (Baltimore); 2021 May; 100(18):e25591. PubMed ID: 33950936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance.
    Kishimoto C; Shioji K; Hashimoto T; Nonogi H; Lee JD; Kato S; Hiramitsu S; Morimoto SI
    Heart Vessels; 2014 May; 29(3):336-42. PubMed ID: 23702697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of intravenous immunoglobulin and vitamin C on progression of experimental autoimmune myocarditis in mice].
    Hu YF; Gong FQ; Chen LQ; Gu WZ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 37(4):399-406. PubMed ID: 18705014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immune globulin for severe acute myocarditis in children.
    Haque A; Bhatti S; Siddiqui FJ
    Indian Pediatr; 2009 Sep; 46(9):810-1. PubMed ID: 19812428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.
    Maisch B; Pankuweit S
    Herz; 2012 Sep; 37(6):644-56. PubMed ID: 22996288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of intravenous immunoglobulin therapy for bullous pemphigoid by adding immunosuppressive agents: marked improvement in depletion of circulating autoantibodies.
    Czernik A; Bystryn JC
    Arch Dermatol; 2008 May; 144(5):658-61. PubMed ID: 18490594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful intravenous immunoglobulin therapy in a case of acute fulminant myocarditis.
    Ozyiğit T; Unal Z; Ozben B
    Turk Kardiyol Dern Ars; 2011 Jan; 39(1):59-63. PubMed ID: 21358234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-globulin treatment of acute myocarditis in the pediatric population.
    Drucker NA; Colan SD; Lewis AB; Beiser AS; Wessel DL; Takahashi M; Baker AL; Perez-Atayde AR; Newburger JW
    Circulation; 1994 Jan; 89(1):252-7. PubMed ID: 8281654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin for presumed viral myocarditis in children and adults.
    Robinson J; Hartling L; Vandermeer B; Klassen TP
    Cochrane Database Syst Rev; 2015 May; (5):CD004370. PubMed ID: 25992494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intravenous immunoglobulin for fulminant myocarditis on in-hospital mortality: propensity score analyses.
    Isogai T; Yasunaga H; Matsui H; Tanaka H; Horiguchi H; Fushimi K
    J Card Fail; 2015 May; 21(5):391-397. PubMed ID: 25639690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.